Arrowstreet Capital’s Cellcom Israel, Ltd. CEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-630,061
Closed -$3.11M 2685
2020
Q4
$3.11M Sell
630,061
-365,930
-37% -$1.61M ﹤0.01% 1424
2020
Q3
$4.07M Buy
995,991
+335,242
+51% +$1.26M 0.01% 1241
2020
Q2
$2.59M Buy
+660,749
New +$2.3M ﹤0.01% 1357
2019
Q3
Sell
-35,913
Closed -$103K 1798
2019
Q2
$103K Sell
35,913
-230,574
-87% -$890K ﹤0.01% 1336
2019
Q1
$965K Buy
266,487
+249,818
+1,499% +$1.2M ﹤0.01% 1329
2018
Q4
$99K Buy
+16,669
New +$109K ﹤0.01% 1307
2018
Q3
Sell
-108,240
Closed -$615K 1336
2018
Q2
$615K Buy
+108,240
New +$735K ﹤0.01% 880

Other funds holding CEL

Arrowstreet Capital's CEL Position: Q1 2021 in Review

Arrowstreet Capital sold out of Cellcom Israel, Ltd. (CEL) in Q1 2021, closing a stake of 630,061 shares — an estimated $3.11M sold.

Arrowstreet Capital first reported a position in CEL in Q2 2018 and held it in 7 quarters. The position peaked at $4.07M in Q3 2020. 12 funds tracked by Wall St. Rank hold CEL as of Q1 2021.

  • Arrowstreet Capital reported no remaining Cellcom Israel, Ltd. position as of Q1 2021 after selling out during the quarter.
  • Arrowstreet Capital sold 630,061 Cellcom Israel, Ltd. shares in Q1 2021, an estimated $3.11M.
  • Arrowstreet Capital first reported a position in Cellcom Israel, Ltd. in Q2 2018 and held it in 7 quarters.
  • Arrowstreet Capital's Cellcom Israel, Ltd. position peaked at $4.07M in Q3 2020.
  • 12 funds tracked by Wall St. Rank held Cellcom Israel, Ltd. as of Q1 2021.

Based on Arrowstreet Capital's 13F filing for Q1 2021, filed 14 May 2021.